May 26, 2026In This Article
Adult vaccines don’t lengthen your life. They protect it from dementia.
Vaccines are one of the best deals in medicine: a few shots, decades of protection, at a cost almost nothing else in healthcare can match. On a longevity site, though, the question is narrower. Not whether they work against the disease on the label (they do), but whether they change how long, and how well, you actually live.
The answer is more interesting than either side expects.
Start with the worry, because most vaccine hesitancy isn’t really about the targeted disease. It’s a suspicion that the shot does something else, something that surfaces years later. For the childhood schedule, that fear has long centered on autism. For the COVID vaccines, it’s been the heart. The common thread is a hidden, delayed cost.
Vaccines Don’t Shorten Life
So look for the cost. A 2025 JAMA Network Open study followed 28.6 million mRNA-COVID-vaccinated French adults for four years and explicitly tested whether they died at higher rates from cancer, heart disease, accidents, or anything else not related to COVID.1 No increase across any major cause. The 11-million-person CDC Vaccine Safety Datalink came back the same way.
COVID vaccines are simply the most-scrutinized in history, but the verdict isn’t specific to them. A 2021 systematic review in Vaccine pooled 338 controlled studies covering every vaccine on the routine US schedule, childhood and adult.2 It found no credible link to serious harm. That includes, with high confidence, no link between the MMR vaccine and autism, and no safety signal for the adult shingles and flu vaccines. The most-investigated question in modern medicine has a boring answer: the shots don’t do hidden damage.
One honest complication is worth naming. Some of the diseases vaccines prevent genuinely do shorten life: measles and diphtheria (a throat infection that suffocated children) once killed kids in large numbers. So why doesn’t skipping those shots show up as lost years for an individual today? Herd immunity. Where almost everyone is vaccinated, the diseases stay rare enough that an unvaccinated person seldom even encounters them. The protection is real. It’s just being supplied by everyone else, and it lasts only as long as coverage stays high. (Measles is already creeping back where it has slipped.) For an individual in a well-vaccinated country, the lifespan math comes out close to neutral.
Vaccines Don’t Extend Life
Run the test the other way: does the shot add years? Here too, the answer is no, at least not beyond protection from the targeted disease itself. A generalized lifespan boost has been hunted for decades by vaccine manufacturers, public health agencies, and longevity researchers. Nobody has found one. The CAPiTA trial gave 84,496 older adults the pneumococcal conjugate vaccine or placebo and followed them for years: vaccine-type pneumonia dropped 38%, vaccine-type invasive disease dropped 76%, and all-cause mortality didn’t budge (relative risk 1.00, 95% CI 0.95-1.05).3 The shot did its labeled job. It didn’t lower deaths from anything else.
So if you score adult vaccines purely on lifespan, the verdict is: neutral. Your raw years on Earth, on the data we have, don’t measurably change. Take them anyway, because herd immunity runs both ways. Your flu and Tdap shots are someone else’s protection from diseases that still kill the very young and the immunocompromised.
But lifespan isn’t the only thing worth measuring.
The Payoff: Dementia Delayed
Here’s what a lifespan number misses. Dying at 85 is one thing; dying at 85 after a final decade lost to dementia is something else entirely. Dementia is how a great many long lives now end. Half of Americans over 85 have dementia or a precursor condition.4 It is the modal way a long life ends badly.
That’s the part of aging adult vaccines actually move: not the date on the death certificate, but the quality of the years before it. And on dementia, the evidence is unusually clean.
Wales: A 20% Drop in Dementia
In 2013, the NHS in Wales rolled out shingles vaccination,5 but only to people whose 80th birthday fell on or after September 2, 2013. Anyone whose 80th birthday fell even one week earlier was ineligible for life. The cutoff was bureaucratic. Zostavax wasn’t cost-effective past 80, so the JCVI capped eligibility there.
The result was a regression discontinuity researchers dream about. Vaccine uptake jumped from 0.01% (one week too old) to 47.2% (one week younger). Two groups of 80-year-olds, statistically identical on every measurable axis, separated only by a calendar boundary.
Seven years later, the eligible group had a 20% lower rate of new dementia diagnoses.
For context: lecanemab and donanemab, the two FDA-approved Alzheimer’s drugs, slow cognitive decline by 25-30% in already-symptomatic patients, at $26,000 to $32,000 per year, with brain swelling and microhemorrhages as common side effects. The shingles shot is $200 retail, fully covered by Medicare in the US and free under the NHS in the UK, and it’s preventing the disease, not just slowing it after the damage is done.
The same study also tested all-cause mortality: did vaccinated people die at lower rates from cancer, heart disease, or anything else outside the brain? It came up null. Wales gives both halves of the verdict in a single experiment: no lifespan effect outside the brain, a substantial protective effect inside it.
A 2025 follow-up in Cell extended the finding.6 Among patients with dementia at baseline, the vaccine reduced dementia-related deaths and added years of life by slowing the disease. It works at multiple stages of the disease course: prevention in the healthy, slowing in the sick.
Every Adult Vaccine Lowers Dementia, Even Rabies
The Wales finding is consistent with a much larger observational literature. A 2022 meta-analysis in Frontiers in Immunology7 found almost every adult vaccine substantially reduced dementia:
- Rabies: 57% lower (HR 0.43)
- BCG: 58% lower (borderline significance)
- Pneumococcal: 32% lower
- Shingles: 31% lower
- Tdap: 31% lower
- Flu: 26% lower
- Hepatitis A, polio, typhoid, hepatitis B: 18-22% lower each
A list like that invites an obvious explanation: maybe these vaccines prevent infections that damage the brain. For shingles, that’s plausible. Varicella-zoster is a neurotropic herpesvirus, and a live hypothesis ties latent herpesviruses to Alzheimer’s.
Rabies rules that out. It’s vanishingly rare, leaves no latent reservoir, and the vaccine still topped the list at 57% lower dementia. Typhoid, polio, and hepatitis A tell the same story.
The benefit can’t be coming from the pathogen the shot targets. It has to come from what the shot does to the immune system.
The likeliest story is trained immunity: a vaccine is a controlled workout, and a trained immune system is better at its housekeeping. It clears senescent cells, catches early cancer, and in the brain, microglia clear the amyloid-β and tau that pile up in dementia. A 2025 meta-analysis in Age and Ageing confirmed the same direction at scale.8
The Future of Vaccines
The next decade of vaccine development looks like the most consequential since the original mRNA platform.
Universal vaccines. A 2022 Science paper from Penn demonstrated a 20-subtype mRNA flu vaccine, every known influenza subtype in one shot. NIH-sponsored phase 1 trials of the same platform began in 2023. The same broad-spectrum approach is being adapted for coronaviruses, RSV, and HSV. About 21 virus families infect humans at all, but only five do most of the disease damage:
- Influenza viruses: the flu
- Coronaviruses: COVID-19, some common colds
- Paramyxoviruses: measles, RSV
- Picornaviruses: common colds, polio
- Herpesviruses: cold sores, shingles, EBV
Close those five families with broad-spectrum vaccines and you shut most of the viral threat surface a healthy adult faces.
Combination vaccines. Vaccines don’t compete with each other. The immune system can handle multiple antigens at once without weakening any single response, which is why we’ve had MMR (measles, mumps, rubella) and Tdap (tetanus, diphtheria, pertussis) for decades, each packing three diseases into one shot. In April 2026, the European Commission approved Moderna’s combined COVID+flu mRNA vaccine for adults 50 and older. Imagine the day when all five core viral families ship in a single annual dose.
Needle-free delivery. Roughly 10% of adults have clinically significant needle phobia, and another 15-20% have non-phobic but real aversion. Nasal vaccines are arriving. Bharat Biotech’s nasal COVID vaccine has been approved in India since 2022. The University of Maryland published phase 1 data in 2025 on an intranasal H5N1 vaccine that produced both mucosal and systemic immunity, something previous nasal vaccines hadn’t managed. Mucosal vaccines have a side benefit: they generate IgA antibodies at the actual site of infection, stopping pathogens at the door instead of after they’re already inside. Sublingual drops and dissolvable-microneedle patches are further out but in development. The hypodermic needle as a delivery mechanism is a 19th-century artifact. It will not survive the next two decades. Add combination vaccines on top, and the five core viral families could land in one annual nasal spray!
What Vaccines to Do Now
Get the vaccines on the adult schedule:
- Flu: every year. Whatever your pharmacy stocks is fine.
- COVID: the current updated vaccine for all adults; a second dose at 65 and older.
- Tdap (tetanus, diphtheria, pertussis): a booster every 10 years.
- Shingles (Shingrix): two doses, 50 and older.
- Pneumococcal (PCV20 or PCV21): one dose, 50 and older.
- RSV: one dose, 75 and older.
Plus, if you don’t have records of childhood immunity, ask your doctor about MMR, varicella, hepatitis B, and hepatitis A. The CDC’s full adult immunization schedule is the comprehensive list.
Most adults are missing pieces of this. RSV gets skipped. Tdap lapses. Pneumococcal, now recommended at 50 rather than 65, gets forgotten. Closing those gaps captures essentially all the benefit the literature shows.
I’m over 55. Shingrix (both doses), COVID, and flu are done. Pneumococcal and Tdap go on this year. RSV waits until 75.
The Simple Math
Do vaccines shorten life? No. The cleanest data on the question is unambiguous.
Do vaccines lengthen life? Also no, at least not beyond protection against the disease they’re labeled for. The cleanest causal evidence on adult vaccines and all-cause mortality found no effect on non-targeted-disease deaths.
But vaccines do cut dementia rates by a substantial margin, in observational data and in the gold-standard Wales natural experiment alike. A better-tuned immune system is doing real work in the brain, well enough that even rabies and typhoid vaccines, which prevent diseases nobody in the developed world dies of, are associated with lower dementia rates.
The case for adult vaccines isn’t longer life. It’s better years. And the future of the platform (universal coverage, combined shots, needle-free delivery) is going to make the same protection easier to take, against a wider range of diseases, without anyone having to roll up a sleeve.
Get the adult schedule on time. Take the dementia benefit. Enjoy a long, clear mind.
